A randomized, phase III, double-blind, placebo-controlled trial of intrapleural instillation of methylprednisolone acetate in the management of malignant pleural effusion

Chest

Volumn 123, Issue 3, 2003, Pages 822-827

  North, Scott A ^a,b   Au, Heather Jane ^a   Halls, Steven B ^a   Tkachuk, Linda ^a   Mackey, John R ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b CROSS CANCER INSTITUTE   (Canada)

Author keywords

Corticosteroids; Intrapleural; Malignancy pleural effusion; Thoracentesis

Indexed keywords

METHYLPREDNISOLONE ACETATE; PLACEBO;

ADULT; AGED; ARTICLE; CANADA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISSEMINATED CANCER; DOUBLE BLIND PROCEDURE; DRUG INSTILLATION; DYSPNEA; ECHOGRAPHY; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PHASE 3 CLINICAL TRIAL; PLEURA CAVITY; PLEURA EFFUSION; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; SYSTEMIC THERAPY; THORACOCENTESIS; TREATMENT OUTCOME; VISUAL ANALOG SCALE;

EID: 0037337425     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.123.3.822     Document Type: Article

References (11)

1. Mackey JR, Wood L, Nabholtz J, et al. A phase II trial of triamcinolone hexacetonide for symptomatic recurrent malignant ascites. J Pain Symptom Manage 2000; 19:193-199
2. Bartal AH, Gazitt Y, Zidan G, et al. Clinical and flow cytometry characteristics of malignant pleural effusions in patients after intracavitary administration of methylprednisolone acetate. Cancer 1991; 67:3136-3140
3. McGavin CR, Artvinli M, Naoe H, et al. Dyspnoea, disability, and distance walked: comparison of estimates of exercise performance in respiratory disease. BMJ 1978; 2:241-243
4. Farncombe M. Dyspnea: assessment and treatment. Support Care Cancer 1997; 5:94-99
5. Cella DF, Tulsky DS, Gray G, et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 1993; 11:570-579
6. Cella D. FACIT manual: manual of the Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System, Version 4, November 1997.
7. Fenton KN, Richardson JD. Diagnosis and management of malignant pleural effusions. Am J Surg 1995; 170:69-74
8. Light RW. Diagnostic principles in pleural disease. Eur Respir J 1997; 10:476-481
9. Sahn SA. Malignant pleural effusions. Clin Chest Med 1985; 6:113-125
10. Walker-Renard PB, Vaughan LM, Sahn SA. Chemical pleurodesis for malignant pleural effusions. Ann Intern Med 1994; 120:56-64
11. Rauthe G, Sistermanns J. Recombinant tumour necrosis factor in the local therapy of malignant pleural effusion. Eur J Cancer 1997; 33:226-233